^
BIOMARKER:

Chr del(13q)

News
Twitter
Trials
Chr del(13q)
Multiple Myeloma
bortezomib
Resistant: C3 – Early Trials
Chr del(13q)
CLL
BMF-219
Sensitive: D – Preclinical